Presence of cognitive and metabolic alterations in AD patients fits with the “Type 3 diabetes” concept, stating that AD brain is insulin-resistant (Talbot et al., 2012; de la Monte, 2014; de la Monte et al., 2018; Nguyen et al., 2020). Here, INS is linked to Alzheimer disease.